Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet in India

Published: 25th July 2020 02:29 PM  |   Last Updated: 25th July 2020 02:30 PM  

Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp